C-Reactive Protein/Albumin and Neutrophil/Albumin Ratios as Novel Inflammatory Markers in Patients with Schizophrenia

키워드

참고문헌 (60)

1. Strous RD, "Schizophrenia, autoimmunity and immune system dysregulation : A comprehensive model updated and revisited", J Autoimmun, 27, pp.71~80 (2006)
2. Müller N, "The role of inflammation in schizophrenia", Front Neurosci, 9, pp.372~ (2015)
3. Potvin S, "Inflammatory cytokine alterations in schizophrenia : a systematic quantitative review", Biol Psychiatry, 63, pp.801~808 (2008)
4. Saetre P, "Inflammation-related genes up-regulated in schizophrenia brains", BMC Psychiatry, 7, pp.46~ (2007)
5. Trépanier MO, "Postmortem evidence of cerebral inflammation in schizophrenia : a systematic review", Mol Psychiatry, 21, pp.1009~1026 (2016)
6. Eaton WW, "Association of schizophrenia and autoimmune diseases : linkage of Danish national registers", Am J Psychiatry, 163, pp.521~528 (2006)
7. Khandaker GM, "Inflammation and immunity in schizophrenia : implications for pathophysiology and treatment", Lancet Psychiatry, 2, pp.258~270 (2015)
8. Leza JC, "Inflammation in schizophrenia : a question of balance", Neurosci Biobehav Rev, 55, pp.612~626 (2015)
9. Kushner I, "The phenomenon of the acute phase response", Ann N Y Acad Sci, 389, pp.39~48 (1982)
10. Ridker PM, "C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women", N Engl J Med, 342, pp.836~843 (2002)
11. Ritchie RF, "Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin : a practical, simple and clinically relevant approach in a large cohort", J Clin Lab Anal, 13, pp.273~279 (1999)
12. Miller BJ, "C-reactive protein levels in schizophrenia : a review and meta-analysis", Clin Schizophr Relat Psychoses, 7, pp.223~230 (2014)
13. Labad J, "Stress biomarkers as predictors of transition to psychosis in atrisk mental states : Roles for cortisol, prolactin and albumin", J Psychiatr Res, 60, pp.163~169 (2015)
14. Chen S, "Association between decreased serum albumin levels and depressive symptoms in patients with schizophrenia in a Chinese Han population : A pilot study", Psychiatry Res, 270, pp.438~442 (2018)
15. Ranzani OT, "C-reactive protein", albumin ratio predicts 90-day mortality of septic patients, 2013, pp.8, e59321~
16. Li N, "Prognostic role of the pretreatment C-reactive protein", albumin ratio in solid cancers : a meta-analysis, 2017, pp.7, 41298~
17. Yazar HO, "Evaluation of simple inflammatory blood parameters in patients with migraine", Ir J Med Sci, 189, pp.677~683 (2020)
18. Olgun Yazar H, "Serum C-reactive protein", albumin ratio and restless legs syndrome, 2019, pp.58, 61~65
19. Yazar T, "Evaluation of C-reactive protein", albumin ratio according to stage in patients with idiopathic parkinson disease, 2019, pp.25, 123~
20. McFarland DC, "Depression and inflammation in patients with lung cancer : a comparative analysis of acute phase reactant inflammatory markers", Psychosomatics (2020)
21. Mazza MG, "Neutrophil", lymphocyte ratio and platelet, Prog Neuro-Psychopharmacology Biol Psychiatry, pp.2018, 84[DOI]
22. Kirlioglu SS, "Comparison of the complete blood count-derived infl ammatory markers in bipolar patients with manic and mixed episodes", Bratislava Med J, 120, pp.195~199 (2019)
23. Mazza MG, "Neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio and platelet-lymphocyte ratio in nonaffective psychosis : a meta-analysis and systematic review", World J Biol Psychiatry, 21, pp.326~338 (2020)
24. Özdin S, "Neutrophil", lymphocyte, platelet, lymphocyte ratios in different stages of schizophrenia, pp.Psychiatry Res, 2019[DOI]
25. Tingle SJ, "NARCA : a novel prognostic scoring system using neutrophil-albumin ratio and Ca19-9 to predict overall survival in palliative pancreatic cancer", J Surg Oncol, 118, pp.680~686 (2018)
26. Andreasen NC, "Remission in schizophrenia : proposed criteria and rationale for consensus", Am J Psychiatry, 162, pp.441~449 (2005)
27. Karageorgiou V, "Neutrophil-to-lymphocyte ratio in schizophrenia : A systematic review and meta-analysis", Schizophr Res, 206, pp.4~12 (2019)
28. Kirsch R, "Regulation of albumin synthesis and catabolism by alteration of dietary protein", Nature, 217, pp.578~579 (1968)
29. Don BR, "Serum albumin : relationship to inflammation and nutrition", Semin Dial, 17, pp.432~437 (2004)
30. Artigas A, "Role of albumin in diseases associated with severe systemic inflammation : Pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis", J Crit Care, 33, pp.62~70 (2016)
31. Kaysen GA, "Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients", Kidney Int, 60, pp.333~340 (2001)
32. Brenner DA, "Tumor necrosis factor-α inhibits albumin gene expression in a murine model of cachexia", J Clin Invest, 85, pp.248~255 (1990)
33. Xu HJ, "The prognostic value of C-reactive protein", albumin ratio in human malignancies : an updated meta-analysis, 2017, pp.10, 3059~3070
34. Kinoshita A, "The C-reactive protein", albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma, 2015, pp.22, 803~810
35. Qin G, "Serum albumin and C-reactive protein", albumin ratio are useful biomarkers of Crohn’s disease activity, 2016, pp.22, 4393~4400
36. Seringec Akkececi N, "The C-reactive protein", albumin ratio and complete blood count parameters as indicators of disease activity in patients with Takayasu arteritis, 2019, pp.25, 1401~1409
37. Saito H, "Prognostic significance of the preoperative ratio of C-reactive protein to albumin and neutrophil–lymphocyte ratio in gastric cancer patients", World J Surg, 42, pp.1819~1825 (2018)
38. Perry VH, "Contribution of systemic inflammation to chronic neurodegeneration", Acta Neuropathol, 120, pp.277~286 (2010)
39. Becher B, "Cytokine networks in neuroinflammation", Nat Rev Immunol, 17, pp.49~59 (2017)
40. Kirkpatrick B, "Inflammation and schizophrenia", Schizophr Bull, 39, pp.1174~1179 (2013)
41. Stojanovic A, "Increased serum interleukin-6 levels in early stages of psychosis : associations with at-risk mental states and the severity of psychotic symptoms", Psychoneuroendocrinology, 41, pp.23~32 (2014)
42. Miller BJ, "Inflammatory biomarkers in schizophrenia : implications for heterogeneity and neurobiology", Biomarkers Neuropsychiatry, 1, pp.1~29 (2019)
43. Borovcanin M, "Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse", J Psychiatr Res, 46, pp.1421~1426 (2012)
44. Borovcanin M, "Antipsychotics can modulate the cytokine profile in schizophrenia : Attenuation of the type-2 inflammatory response", Schizophr Res, 147, pp.103~109 (2013)
45. Miller BJ, "Total and differential white blood cell counts, high-sensitivity C-reactive protein, and the metabolic syndrome in non-affective psychoses", Brain Behav Immun, 31, pp.82~89 (2013)
46. Garcia-Rizo C, "Blood cell count in antipsychotic-naive patients with non-affective psychosis", Early Interv Psychiatry, 13, pp.95~100 (2019)
47. Fan X, "Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia", Psychiatry Res, 149, pp.267~271 (2007)
48. Fan X, "Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia", Schizophr Res, 118, pp.211~217 (2010)
49. Barzilay R, "Elevated C-reactive protein levels in schizophrenia inpatients is associated with aggressive behavior", Eur Psychiatry, 31, pp.8~12 (2016)
50. Müller N, "Celecoxib treatment in an early stage of schizophrenia : Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment", Schizophr Res, 121, pp.118~124 (2010)
51. Heilbronner U, "The longitudinal course of schizophrenia across the lifespan : clinical, cognitive, and neurobiological aspects", Harv Rev Psychiatry, 24, pp.118~128 (2016)
52. Chung HY, "Molecular inflammation : underpinnings of aging and age-related diseases", Ageing Res Rev, 8, pp.18~30 (2009)
53. Fawzi MH, "C-reactive protein serum level in drug-free male Egyptian patients with schizophrenia", Psychiatry Res, 190, pp.91~97 (2011)
54. Semiz M, "Elevated neutrophil", lymphocyte ratio in patients with schizophrenia, 2014, pp.26, 220~225
55. Yüksel RN, "High neutrophil-lymphocyte ratio in schizophrenia independent of infectious and metabolic parameters", Nord J Psychiatry, 72, pp.336~340 (2018)
56. Chase KA, "The value of interleukin 6 as a peripheral diagnostic marker in schizophrenia", BMC Psychiatry, 16, pp.152~ (2016)
57. Zhang Q, "Increased ratio of high sensitivity C-reactive protein to interleukin-10 as a potential peripheral biomarker of schizophrenia and aggression", Int J Psychophysiol, 114, pp.9~15 (2017)
58. Wysokiński A, "Platelet parameters(PLT, MPV, P-LCR)in patients with schizophrenia, unipolar depression and bipolar disorder", Psychiatry Res, 237, pp.238~245 (2016)
59. Upthegrove R, "Cytokine function in medication-naive first episode psychosis : A systematic review and meta-analysis", Schizophr Res, 155, pp.101~108 (2014)
60. Rea IM, "Age and age-related diseases : role of inflammation triggers and cytokines", Front Immunol, 9, pp.586~ (2018)

관련 논문AI추천